Timing clarification: The event date supplied is August 4, 2026, which is today, not tomorrow, in the current context. This preview therefore reflects the setup immediately ahead of Emerson’s FY2026 third-quarter report/call.
Emerson enters Q3 with a relatively well-defined operating plan: management guided to ~5% underlying sales growth, ~28% adjusted segment EBITA margin, and adjusted EPS of $1.65–$1.70. The headline result matters, but the likely stock drivers are whether the company confirms its second-half ramp, sustains strong orders/backlog, and protects its full-year framework amid Middle East disruption, uneven China demand, tariff/freight pressures, and elevated expectations around power, industrial software, and test & measurement.
The core bull case remains intact: Emerson is exposed to multi-year investment themes—especially power/grid modernization, LNG, life sciences, semiconductors, and aerospace & defense—while its large installed base supports resilient MRO revenue. The bear case is that Q3’s planned acceleration requires clean project conversion and continued North American strength just as China, Europe, automotive, and parts of the Middle East remain soft.
| Metric | FY2026 Q3 guide | FY2025 Q3 actual | Read-through |
|---|---|---|---|
| Reported sales growth | ~5.5% | 4% | FX is expected to remain favorable |
| Underlying sales growth | ~5% | 3% | Clear sequential acceleration versus first-half underlying growth |
| Adjusted segment EBITA margin | ~28% | 27.1% | Requires continued pricing/productivity and favorable mix |
| Adjusted EPS | $1.65–$1.70 | $1.52 | Implies roughly 9–12% year-over-year growth |
| Full-year adjusted EPS | $6.45–$6.55 | — | The most important guidance anchor |
| Full-year free cash flow | $3.5B–$3.6B | — | Back-half cash conversion must improve materially |
The Q3 EPS midpoint is $1.675, about 10% above the prior-year quarter. Based on the reported-sales-growth guide, revenue would be roughly $4.8 billion, though actual reported sales will depend on currency and mix.
In fiscal Q2, Emerson delivered:
The key implication: management has already acknowledged the near-term disruptions. Q3 is supposed to demonstrate that the backlog, project funnel, growth-vertical demand, and improving Middle East activity can translate into the expected step-up in revenue and earnings.
Orders are arguably the most important metric. Emerson’s second-half plan relies on converting backlog and maintaining healthy demand in its targeted growth verticals. Investors should look for:
Management previously said it saw mid-single-digit order growth as sustainable into the balance of FY2026, with momentum positioning the company for the first half of FY2027. A meaningful deceleration would undermine that thesis.
Power is Emerson’s most important secular demand vector. In Q2, power-related orders rose 23%, Ovation orders increased 41%, and AspenTech digital-grid-management ACV grew 31%. Emerson cited demand tied to grid modernization, plant life extensions, behind-the-meter generation, and data-center-related power needs.
For Q3, investors should focus on:
A robust update here would reinforce the long-duration growth narrative rather than simply support one quarter’s numbers.
Software & Systems was held back in Q2 by a 4.5-point sales drag from software contract-renewal timing. Management’s Q3 plan calls for ~8% underlying growth in the group, comprising:
That makes this Emerson’s most consequential segment for the Q3 beat/miss.
Within the segment, the highest-value questions are:
Management has been clear that AI is not yet a meaningful FY2026 revenue contributor. The more relevant near-term issue is whether AI functionality strengthens Emerson’s competitive differentiation and pricing in automation, optimization, and testing workflows.
Intelligent Devices was the main Q2 weak spot: underlying sales declined 1%, including an estimated 2-point Middle East impact. Management guides the group to ~4% underlying growth in Q3, driven by backlog phasing, U.S. strength, and growth verticals.
The challenge is that the group remains exposed to weaker markets:
A clean Q3 recovery in Sensors and Final Control would validate management’s second-half plan. Conversely, further volume weakness could pressure the group’s attractive margin profile.
Emerson’s profitability has held up well. In Q2, price/cost, productivity, and mix more than offset inflation, supporting a 27.6% adjusted segment EBITA margin. Q3 guidance implies a further step-up to approximately 28%.
Watch for:
Management’s prior outlook assumed a net-neutral tariff effect: the benefit from removal of IEEPA tariffs offset by Section 122/232 tariffs and freight costs. It also excluded any potential tariff-refund benefit. Any revised outlook or recognition of refunds could become an incremental earnings variable, but investors should not underwrite it absent formal company guidance.
The Middle East remains the largest source of uncertainty, but it also creates potential future demand. Emerson has approximately $1.2 billion of regional sales, or about 7% of company sales, and estimated:
The Q3 call should clarify whether site activity, logistics, field-service capacity, and MRO/project work continue to normalize. A better-than-expected recovery could support upside to revenue timing; renewed disruption would place the full-year sales guide at risk.
Cash conversion is a secondary—but important—watch item. Emerson reaffirmed FY2026 operating cash flow of $4.0B–$4.1B and free cash flow of $3.5B–$3.6B. First-half free cash flow was only $1.296B, depressed by working-capital investment, tax timing, and the setup for stronger second-half shipments.
Management expects to return about $2.2B to shareholders in FY2026, including approximately $1.2B of dividends and $1.0B of repurchases. It had completed $542M of repurchases through the first half.
The investor question is straightforward: does Q3 show the working-capital unwind and cash-flow trajectory needed to make the full-year target credible?
EMR closed at $154.88 on August 3, up roughly 11.0% from July 1 and 11.9% from May 5. That run suggests investors are already giving credit for the power/automation growth narrative and the anticipated second-half execution ramp.
As a result, simply meeting the EPS range may not be enough for a strong reaction. The market is likely to reward evidence of stronger orders, clean segment execution, and confidence in FY2026/FY2027 growth; it is likely to penalize any full-year de-risking tied to project conversion, China, Middle East disruption, or margin pressure.
Base case: Emerson delivers results around its guided Q3 range, with Software & Systems and Test & Measurement driving the planned acceleration, while margins remain near 28%. Full-year guidance is reiterated.
Bull case: Orders remain mid- to high-single-digit, power and T&M exceed expectations, Middle East activity improves faster than assumed, and management expresses greater confidence in the second-half conversion and FY2027 setup.
Bear case: Backlog conversion slips, Intelligent Devices fails to rebound, China/Europe weakness broadens, Middle East disruption persists, or mix/tariffs/freight prevent the targeted margin expansion. In that case, the market would likely question the full-year sales and free-cash-flow framework.
Research basis: Emerson FY2026 Q2 earnings release, earnings-call transcript, and March 31, 2026 Form 10-Q; Emerson FY2025 Q3 earnings release; historical EMR price data.